Triggering receptor expressed on myeloid cells and 5’adenosine monophosphate-activated protein kinase in the inflammatory response

a potential therapeutic target

Finosh G. Thankam, Matthew Dilisio, Kaitlin A. Dougherty, Nicholas E. Dietz, Devendra K. Agrawal

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Introduction: The events in the cellular and molecular signaling triggered during inflammation mitigate tissue healing. The metabolic check-point control mediated by 5ʹ-adenosine monophosphate-activated protein kinase (AMPK) is crucial for switching the cells into an activated state capable of mediating inflammatory events. The cell metabolism involved in the inflammatory response represents a potential therapeutic target for the pharmacologic management of inflammation. Areas covered: In this article, a critical review is presented on triggering receptor expressed on myeloid cell (TREM) receptors and their role in the inflammatory responses, as well as homeostasis between different TREM molecules and their regulation. Additionally, we discussed the relationship between TREM and AMPK to identify novel targets to limit the inflammatory response. Literature search was carried out from the National Library of Medicine’s Medline database (using PubMed as the search engine) and Google Scholar and identified relevant studies up to 30 March 2016 using inflammation, TREM, AMPK, as the key words. Expert commentary: The prevention of phenotype switching of immune cells during inflammation by targeting AMPK and TREM-1 could be beneficial for developing novel management strategies for inflammation and associated complications.

Original languageEnglish (US)
Pages (from-to)1239-1249
Number of pages11
JournalExpert Review of Clinical Immunology
Volume12
Issue number11
DOIs
StatePublished - Nov 1 2016

Fingerprint

Myeloid Cells
Protein Kinases
Adenosine Monophosphate
Inflammation
National Library of Medicine (U.S.)
Therapeutics
Search Engine
PubMed
Homeostasis
Databases
Phenotype

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Triggering receptor expressed on myeloid cells and 5’adenosine monophosphate-activated protein kinase in the inflammatory response : a potential therapeutic target. / Thankam, Finosh G.; Dilisio, Matthew; Dougherty, Kaitlin A.; Dietz, Nicholas E.; Agrawal, Devendra K.

In: Expert Review of Clinical Immunology, Vol. 12, No. 11, 01.11.2016, p. 1239-1249.

Research output: Contribution to journalReview article

@article{741a3eea4a214cd1a4ec8d2e2940d7a9,
title = "Triggering receptor expressed on myeloid cells and 5’adenosine monophosphate-activated protein kinase in the inflammatory response: a potential therapeutic target",
abstract = "Introduction: The events in the cellular and molecular signaling triggered during inflammation mitigate tissue healing. The metabolic check-point control mediated by 5ʹ-adenosine monophosphate-activated protein kinase (AMPK) is crucial for switching the cells into an activated state capable of mediating inflammatory events. The cell metabolism involved in the inflammatory response represents a potential therapeutic target for the pharmacologic management of inflammation. Areas covered: In this article, a critical review is presented on triggering receptor expressed on myeloid cell (TREM) receptors and their role in the inflammatory responses, as well as homeostasis between different TREM molecules and their regulation. Additionally, we discussed the relationship between TREM and AMPK to identify novel targets to limit the inflammatory response. Literature search was carried out from the National Library of Medicine’s Medline database (using PubMed as the search engine) and Google Scholar and identified relevant studies up to 30 March 2016 using inflammation, TREM, AMPK, as the key words. Expert commentary: The prevention of phenotype switching of immune cells during inflammation by targeting AMPK and TREM-1 could be beneficial for developing novel management strategies for inflammation and associated complications.",
author = "Thankam, {Finosh G.} and Matthew Dilisio and Dougherty, {Kaitlin A.} and Dietz, {Nicholas E.} and Agrawal, {Devendra K.}",
year = "2016",
month = "11",
day = "1",
doi = "10.1080/1744666X.2016.1196138",
language = "English (US)",
volume = "12",
pages = "1239--1249",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",
number = "11",

}

TY - JOUR

T1 - Triggering receptor expressed on myeloid cells and 5’adenosine monophosphate-activated protein kinase in the inflammatory response

T2 - a potential therapeutic target

AU - Thankam, Finosh G.

AU - Dilisio, Matthew

AU - Dougherty, Kaitlin A.

AU - Dietz, Nicholas E.

AU - Agrawal, Devendra K.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Introduction: The events in the cellular and molecular signaling triggered during inflammation mitigate tissue healing. The metabolic check-point control mediated by 5ʹ-adenosine monophosphate-activated protein kinase (AMPK) is crucial for switching the cells into an activated state capable of mediating inflammatory events. The cell metabolism involved in the inflammatory response represents a potential therapeutic target for the pharmacologic management of inflammation. Areas covered: In this article, a critical review is presented on triggering receptor expressed on myeloid cell (TREM) receptors and their role in the inflammatory responses, as well as homeostasis between different TREM molecules and their regulation. Additionally, we discussed the relationship between TREM and AMPK to identify novel targets to limit the inflammatory response. Literature search was carried out from the National Library of Medicine’s Medline database (using PubMed as the search engine) and Google Scholar and identified relevant studies up to 30 March 2016 using inflammation, TREM, AMPK, as the key words. Expert commentary: The prevention of phenotype switching of immune cells during inflammation by targeting AMPK and TREM-1 could be beneficial for developing novel management strategies for inflammation and associated complications.

AB - Introduction: The events in the cellular and molecular signaling triggered during inflammation mitigate tissue healing. The metabolic check-point control mediated by 5ʹ-adenosine monophosphate-activated protein kinase (AMPK) is crucial for switching the cells into an activated state capable of mediating inflammatory events. The cell metabolism involved in the inflammatory response represents a potential therapeutic target for the pharmacologic management of inflammation. Areas covered: In this article, a critical review is presented on triggering receptor expressed on myeloid cell (TREM) receptors and their role in the inflammatory responses, as well as homeostasis between different TREM molecules and their regulation. Additionally, we discussed the relationship between TREM and AMPK to identify novel targets to limit the inflammatory response. Literature search was carried out from the National Library of Medicine’s Medline database (using PubMed as the search engine) and Google Scholar and identified relevant studies up to 30 March 2016 using inflammation, TREM, AMPK, as the key words. Expert commentary: The prevention of phenotype switching of immune cells during inflammation by targeting AMPK and TREM-1 could be beneficial for developing novel management strategies for inflammation and associated complications.

UR - http://www.scopus.com/inward/record.url?scp=84992121843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992121843&partnerID=8YFLogxK

U2 - 10.1080/1744666X.2016.1196138

DO - 10.1080/1744666X.2016.1196138

M3 - Review article

VL - 12

SP - 1239

EP - 1249

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 11

ER -